Carbapenems, a new class of beta-lactam antibiotics. Discovery and development of imipenem/cilastatin
about
sameAs
Definition of the common and divergent steps in carbapenem β-lactam antibiotic biosynthesisBiochemical and Structural Characterization of Mycobacterium tuberculosis β-Lactamase with the Carbapenems Ertapenem and DoripenemNatural Variants of the KPC-2 Carbapenemase have Evolved Increased Catalytic Efficiency for Ceftazidime Hydrolysis at the Cost of Enzyme StabilityRapid identification of carbapenemase genes in gram-negative bacteria with an oligonucleotide microarray-based assayEffects of antibiotic therapy on Pseudomonas aeruginosa-induced lung injury in a rat model.Biochemical characterization of novel tetrahydrofuranyl 1beta-methylcarbapenems: stability to hydrolysis by renal dehydropeptidases and bacterial beta-lactamases, binding to penicillin binding proteins, and permeability properties.Pharmacokinetics of imipenem-cilastatin in critically ill patients undergoing continuous venovenous hemofiltration.Assessment of the role of renal organic anion transporters in drug-induced nephrotoxicity.Therapeutic effects of imipenem-cilastatin on experimental intrauterine infections in rats.Biliary excretion of imipenem-cilastatin in hospitalized patients.A prospective randomized trial of imipenem-cilastatin versus clindamycin/tobramycin in the treatment of intra-abdominal and pelvic infectionsAsymmetric catalysis: an enabling scienceGap junction inhibition prevents drug-induced liver toxicity and fulminant hepatic failure.Pharmacokinetics and transplacental passage of imipenem during pregnancy.Carbapenems in the USA: focus on doripenem.Effects of treatment with antimicrobial agents on the human colonic microfloraIdentification of Streptococcus faecalis and Streptococcus faecium and susceptibility studies with newly developed antimicrobial agentsTentative interpretive criteria for in vitro antibacterial susceptibility testing with imipenem.Bibliometric analysis of global scientific research on carbapenem resistance (1986-2015)Molecular-targeted approaches to reduce renal accumulation of nephrotoxic drugs.Klebsiella pneumoniae carbapenemases in Enterobacteriaceae: history, evolution, and microbiology concerns.Antimicrobial therapy for the elderly patient.Extended spectrum β-lactamases, carbapenemases and mobile genetic elements responsible for antibiotics resistance in Gram-negative bacteria.Xenobiotic transporters and kidney injury.Imipenem-antibiotic monotherapy in juvenile cancer patients with neutropenia.In vitro antibacterial activity of LJC 11,036, an active metabolite of L-084, a new oral carbapenem antibiotic with potent antipneumococcal activityImipenem monotherapy versus combination therapy in the management of mixed bacterial infection: a critical appraisal.In vitro activity against aerobic and anaerobic gram-positive and gram-negative bacteria and beta-lactamase stability of RS-533, a novel carbapenem.Renal dehydropeptidase-I stability of LJC 10,627, a new carbapenem antibiotic.Extended infusion versus intermittent infusion of imipenem in the treatment of ventilator-associated pneumonia.Inhibition by carbapenem antibiotic imipenem of intestinal absorption of valproic acid in rats.Cisplatin-induced renal inflammation is ameliorated by cilastatin nephroprotection.Structural Elucidation of β-Lactam Diastereoisomers through Ion Mobility Mass Spectrometry Studies and Theoretical Calculations.Carbapenem Resistance: A Review.Post-antibiotic effect of FK-037 and biapenem tested against five bacterial species.
P2860
Q24631958-0528940F-BA79-4EF1-ADED-813BE9E17F63Q24631958-17D17ADA-2BF5-4541-8BDA-1590FE19FA7FQ27660367-A0B1B8A6-EED8-4114-ABEE-7656C2CE334BQ27660367-C111AA4C-EEC9-435C-90D3-E95DC330C126Q28547682-A2507B4F-4BD8-4F9A-814C-C878531D1868Q28547682-DA8CB7FC-4D64-4455-80F9-B5C8C0C0EADCQ33960560-0C0768F3-9E54-45EF-8637-F20642AB0CE7Q33977810-59AAFDC9-7FA2-4438-A984-14D0F290D799Q33978241-FA7C5B63-3E1D-49F4-B91E-46ADCFFCD672Q35139365-BA50D13B-55AF-4C3C-A5FB-10073082DB2DQ35155913-E36E11EB-3BBF-4599-B411-95BDBFD0B881Q35538772-852292B9-27B5-47E8-84E7-E4DE05C794FDQ35543208-C230DA47-E7B1-4A17-8485-6B93F5478DB6Q35649774-7ABFA3FF-9112-47A5-9786-9C6C0884BE5DQ35678271-10CFE8FD-EA65-4992-92D6-CEEAFF322B00Q36720833-94657CF9-F328-4020-B7A5-D7DD661E609DQ36758177-E855EDBE-51BB-43CC-B49C-62E49D163FDFQ36960048-5B716037-0C20-4B98-ADD7-D888698BE2D9Q37098178-2BEFC69B-F545-4167-8C72-1594D247DF75Q37140402-8FB50ECD-6489-43CB-B7F6-105CD035664FQ37202914-9FF78320-E509-464A-B2A4-62F32870503BQ37280844-DFC387F1-0609-4312-96A2-54FA68E2D66BQ37763924-A5729A68-C6C4-4B54-971A-BC050F35AC14Q38001333-EAD0AC4D-F84B-4CCC-A3A4-BF4966EA081BQ38006505-62F8A169-A4A1-4764-B3CC-481115547EB2Q38016195-94885D6E-48B8-4CC7-B3BB-BFF41123CC82Q39098252-91FDCC69-2AC4-447C-8227-F6AA267DBA53Q39261281-4EF7B988-FEBE-4CDB-8B7A-F2773858288CQ39471526-976E843D-07A2-4051-A477-EC9D4F76C227Q39619846-15F9E144-EFAE-48F2-8E67-DC77FA2718C2Q39851663-6C9535FB-62D1-4D62-9085-0B785F58C2D2Q39867998-1AEB30A3-D365-4256-AB2A-BA74871A077FQ41354782-47D9C255-5749-4717-A12B-3843C7F0B604Q43655077-306D76DA-07DD-4328-9411-202E8105CF7AQ48807960-429958A8-EE89-4D1F-9813-5136CA093994Q50675197-8B6ED0FA-5102-4E95-BAB3-4A3C1E5CD972Q53714289-752CF221-8890-441E-9B79-DFB7E587829BQ54641937-895A0A1F-942F-4145-B2D2-91AB2FCBA55B
P2860
Carbapenems, a new class of beta-lactam antibiotics. Discovery and development of imipenem/cilastatin
description
1985 nî lūn-bûn
@nan
1985 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
Carbapenems, a new class of be ...... lopment of imipenem/cilastatin
@ast
Carbapenems, a new class of be ...... lopment of imipenem/cilastatin
@en
Carbapenems, a new class of be ...... lopment of imipenem/cilastatin
@nl
type
label
Carbapenems, a new class of be ...... lopment of imipenem/cilastatin
@ast
Carbapenems, a new class of be ...... lopment of imipenem/cilastatin
@en
Carbapenems, a new class of be ...... lopment of imipenem/cilastatin
@nl
altLabel
Carbapenems, a new class of beta-lactam antibiotics
@ast
Carbapenems, a new class of beta-lactam antibiotics
@en
prefLabel
Carbapenems, a new class of be ...... lopment of imipenem/cilastatin
@ast
Carbapenems, a new class of be ...... lopment of imipenem/cilastatin
@en
Carbapenems, a new class of be ...... lopment of imipenem/cilastatin
@nl
P2093
P3181
P1476
Carbapenems, a new class of beta-lactam antibiotics
@en
Carbapenems, a new class of be ...... lopment of imipenem/cilastatin
@en
P2093
Frederick M. Kahan
Helmut Kropp
J Birnbaum
J S MacDonald
James S. Macdonald
Jerome Birnbaum
P3181
P356
10.1016/0002-9343(85)90097-X
P407
P577
1985-06-01T00:00:00Z
1985-06-07T00:00:00Z